1. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). (March 2015) Authors: Andrews, PW; Baker, D; Benvinisty, N; Miranda, B; Bruce, K; Brüstle, O; Choi, M; Choi, Y-M; Crook, JM; de Sousa, PA; Dvorak, P; Freund, C; Firpo, M; Furue, MK; Gokhale, P; Ha, H-Y; Han, E; Haupt, S; Healy, L; Hei, DJ Journal: Regenerative medicine Issue: Volume 10:Number 2(2015)Supplement Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Industry Responsibilities in Tackling Direct‐to‐Consumer Marketing of Unproven Stem Cell Treatments. Issue 2 (10th July 2017) Authors: Master, Z; Fu, W; Paciulli, D; Sipp, D Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 2(2017) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗